Drug Shortage Report for BIO-EZETIMIBE

Last updated on 2020-02-07 History
Report ID 103954
Drug Identification Number 02425211
Brand name BIO-EZETIMIBE
Common or Proper name EZETIMIBE
Company Name BIOMED PHARMA
Market Status MARKETED
Active Ingredient(s) EZETIMIBE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-01-20
Estimated end date
Actual end date 2020-02-06
Shortage status Resolved
Updated date 2020-02-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-02-07 English Compare
v4 2020-02-06 French Compare
v3 2020-02-06 English Compare
v2 2020-01-22 French Compare
v1 2020-01-22 English Compare

Showing 1 to 5 of 5